Home / About us / Our team / Stephanie Monaco

Stephanie Monaco

General Counsel & Head of Regulatory Affairs

Stephanie Monaco brings over 20 years of experience advising pharmaceutical clients and providing expert legal and regulatory guidance to her role at Kindeva.

Stephanie has built an impressive career and brings more than 20 years of experience advising pharmaceutical clients to Kindeva Drug Delivery. Most recently, Stephanie served as Vice President of Intellectual Property and Deputy General Counsel for Upjohn, a former division of Pfizer, Inc. There, she was responsible for legal matters related to intellectual property, litigation, licensing and business development, and corporate governance, as well as regulatory, privacy and public policy. During Stephanie’s 17 years with Pfizer, she held several other positions, including lead intellectual property counsel for Meridian Medical Technologies.

Stephanie studied biochemistry at Rutgers University and earned a B.A. from the University of New Hampshire and a JD from Seton Hall University School of Law.

How can Stephanie help you?

  • Her expertise in intellectual property helps you develop and implement effective IP strategies to protect your innovations and maintain a competitive advantage

  • Stephanie’s experience with regulatory, privacy and public policy matters ensures you receive sound legal advice and guidance on navigating the complex regulatory landscape

  • Her involvement in licensing and business development activities gives you valuable support in your strategic partnerships and transactions

  • Stephanie’s experience in litigation management helps you navigate legal disputes effectively and protect your interests

  • Her 20+years of advising clients gives her a deep understanding of the industry’s unique legal and business challenges, allowing her to provide tailored and effective counsel

See who else is in the team

Discover a team with technical expertise and a passion for purpose, dedicated to helping you manufacture more tomorrows and transform the future of drug delivery.

Milton Boyer

Chief Executive Officer

Read bio

David Stevens

Chief Commercial Officer and Chief Operations Officer

Read bio

Robert Berg

Chief Financial Officer

Read bio